...
首页> 外文期刊>Pediatrics Neonatology >Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants – Impact on outcome and pain perception
【24h】

Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants – Impact on outcome and pain perception

机译:预防性低剂量扑热息痛的给药与早产儿动脉导管未闭的发生率降低有关–对预后和疼痛感的影响

获取原文
           

摘要

Background To determine the rate of patent ductus arteriosus after prophylactic low-dose paracetamol administration, the impact on outcome parameters, possible treatment side-effects and the influence on pain perception. Methods We report retrospective single-centre outcome data of premature infants ≤ 32 weeks of gestation (n = 476). The intervention group received intravenous paracetamol, the control group obtained no preventive therapy. Ductal closure rate and outcome parameters were compared between the two groups. Adverse effects were determined by laboratory parameters. For the assessment of pain the Bernese Pain Scale for Neonates was used. Results The rate of patent ductus arteriosus was significantly lower in the paracetamol-treated group compared to the control group (13.6% vs. 38.2%, p 0.001). With regard to secondary outcome parameters, severe and moderate bronchopulmonary dysplasia (2.7% vs. 7.4%, p = 0.023), severe retinopathy of prematurity (0% vs. 4.4%, p = 0.002) and late onset sepsis (2.7% vs. 8.3%, p = 0.009) were significantly less frequent in the paracetamol group. Except for a 1.5-fold increased risk for hyperbilirubinemia (86.0% vs. 77.6%, p = 0.035) in the paracetamol group following treatment, no significant differences in laboratory parameters were found. Relating to pain, the administration of Glucose 33% was significantly more often necessary in the control group compared to the paracetamol-treated group (mean 13.48 vs. 8.71, p 0.001), just as the need for additional treatment with systemic analgesics, which was more frequent in the control group (mean 0.72 vs. 0.57, p = 0.361). Conclusion In our study we were able to show a significantly lower rate of patent ductus arteriosus after prophylactic paracetamol administration without serious adverse effect, but a beneficial influence of this regime on the patient's pain perception.
机译:背景为了确定预防性小剂量扑热息痛给药后动脉导管未闭的发生率,对结局参数的影响,可能的治疗副作用以及对疼痛知觉的影响。方法我们报告了≤32周(n = 476)的早产儿的回顾性单中心结果数据。干预组接受静脉对乙酰氨基酚,对照组未获得预防性治疗。比较两组的导管闭合率和结局参数。不良反应由实验室参数确定。为了评估疼痛,​​使用了新生儿伯尔尼疼痛量表。结果扑热息痛治疗组的动脉导管未闭发生率明显低于对照组(13.6%vs. 38.2%,p <0.001)。关于次要结局参数,重度和中度支气管肺发育不良(2.7%vs. 7.4%,p = 0.023),严重的早产儿视网膜病变(0%vs. 4.4%,p = 0.002)和迟发性败血症(2.7%vs。扑热息痛组中8.3%,p = 0.009)的发生率显着降低。除扑热息痛组治疗后高胆红素血症风险增加1.5倍(86.0%比77.6%,p = 0.035)外,实验室参数无显着差异。关于疼痛,与对乙酰氨基酚治疗的组相比,对照组中服用葡萄糖33%的比例明显更高(平均13.48 vs. 8.71,p <0.001),就像需要全身性镇痛药进行其他治疗一样。在对照组中更为频繁(平均0.72比0.57,p = 0.361)。结论在我们的研究中,我们能够显示出扑热息痛预防性使用后动脉导管未闭的比率显着降低,而没有严重的不良反应,但是这种治疗方案对患者的疼痛感产生了有益的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号